Multidimensional sensory phenomena in antipsychotic-induced akathisia

Journal of Clinical Psychopharmacology

Volumn 24, Issue 6, 2004, Pages 618-623

  Kim, Jong Hoon ^a   Cho, Sang Yong ^a   Byun, Hee Jung ^b   Kang, Ung Gu ^c   Ahn, Yong Min ^c   Kim, Yong Sik ^c,d  

^a Gachon University   (South Korea)

^b Yongin Mental Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; AKATHISIA; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG INDUCED DISEASE; DYSPNEA; EDUCATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY DYSFUNCTION; TARDIVE DYSKINESIA;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SENSATION DISORDERS;

EID: 8744313917     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000145343.76288.f7     Document Type: Article

References (36)

1. Adler LA, Angrist B, Reiter S, et al. Neuroleptic-induced akathisia: a review. Psychopharmacology. 1989;97:1-11.
2. Barnes TR, McPhillips MA. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br J Psychiatry Suppl. 1999;38:34-43.
3. Hansen L. A critical review of akathisia, and its possible association with suicidal behaviour. Hum Psychopharmacol. 2001;16:495-505.
4. Kaye NS. Psychic akathisia. J Clin Psychopharmacol. 2003;23:206.
5. Kim JH, Lee BC, Park HJ, et al. Subjective emotional experience and cognitive impairment in drug-induced akathisia. Compr Psychiatry. 2002;43:456-462.
6. Hirose S. The causes of underdiagnosing akathisia. Schizophr Bull. 2003;29:547-558.
7. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672-676.
8. Sachdev P. Akathisia: development of the concept. In: Sachdev P, ed. Akathisia and Restless Legs. New York: Cambridge University Press; 1995:3-17.
9. Owens DGC. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge: Cambridge University Press; 1999.
10. Rubey RN, Arana GW. Cognitive akathisia: clinical and theoretical aspects. In: Joseph AB, Young RR, eds. Movement Disorders in Neurology and Neuropsychiatry. 2nd ed. Malden: Blackwell Science Inc; 1999:84-88.
11. Rey MJ, Schulz P, Costa C, et al. Guidelines for the dosage of neuroleptics. I. Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol. 1989;4:95-104.
12. Meyer JM, Simpson GM. Anticholinergics and amantadine. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:2276-2282.
13. Ballenger JC. Benzodiazepine receptor agonists and antagonists. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:2317-2324.
14. Halstead SM, Barnes TRE, Speller JC. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry. 1994;164:177-183.
15. Nair CJ, Josiassen RC, Abraham G, et al. Does akathisia influence psychopathology in psychotic patients treated with clozapine? Biol Psychiatry. 1999;45:1376-1383.
16. Cem Atbasoglu E, Schultz SK, Andreasen NC. The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J Neuropsychiatry Clin Neurosci. 2001;13:336-341.
17. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11-19.
18. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda, MD: US Department of Health, Education, and Welfare; 1976. Publication ADM 76-338 ed.
19. Krawiecka M, Goldberg D, Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand. 1977;55:299-308.
20. Miguel EC, Coffey BJ, Baer L, et al. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 1995;56:246-255.
21. Miguel EC, do Rosario-Campos MC, Prado HS, et al. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 2000;61:150-156.
22. Kim JH, Jung HY, Kang UG, et al. Metric characteristics of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders. Mov Disord. 2002;17:1354-1359.
23. Kim JH, Byun HJ. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects. Clin Neuropharmacol. 2003;26:312-316.
24. Braude WM, Barnes TR, Gore SM. Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry. 1983;143:139-150.
25. Obeso JA, Rothwell JC, Marsden CD. Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry. 1981;44:735-738.
26. Lang AE, Johnson K. Akathisia in idiopathic Parkinson's disease. Neurology. 1987;37:477-481.
27. Cohen AJ, Leckman JF. Sensory phenomena associated with Gilles de la Tourette's syndrome. J Clin Psychiatry. 1992;53:319-323.
28. Kendler KS. A medical student's experience with akathisia. Am J Psychiatry. 1976;133:454.
29. Gruber O, Northoff G, Pflug B. Subjective experiences of patients with acute neuroleptic-induced akathisia. Fortschr Neurol Psychiatr. 1998;66:531-538.
30. Krüger S, Bräunig P, Höffler J, et al. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12:16-24.
31. Zald DH, Kim SW. Anatomy and function of the orbital frontal cortex. II. Function and relevance to obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 1996;8:249-261.
32. Comella CL, Goetz CG. Akathisia in Parkinson's disease. Mov Disord. 1994;9:545-549.
33. Micieli G, Tosi P, Marcheselli S, et al. Autonomic dysfunction in Parkinson's disease. Neurol Sci. 2003;24(Suppl 1)S32-S34.
34. Van Putten T, May PR, Marder SR. Akathisia with haloperidol and thiothixene. Arch Gen Psychiatry. 1984;41:1036-1039.
35. Sachdev P, Kruk J. Clinical characteristics and predisposing factors in acute drug-induced akathisia. Arch Gen Psychiatry. 1994;51:963-974.
36. Sachdev P. Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal. Psychopharmacology. 1994;114:181-186.